InsidersTradesSigma
Browse the full record of transactions filed by FRATTAROLI JOSEPH, Chief Financial Officer. Officer active across 1 company, notably Inhibikase Therapeutics, Inc.. Aggregated, 1 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €2k. Activity tracked since 19 May 2022. The latest transaction was filed on 19 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
1 of 1 declaration
Frattaroli Joseph is the Chief Financial Officer at Inhibikase Therapeutics, Inc. He is responsible for the financial management of the company, including financial planning and analysis. His expertise is essential to support the company's growth and profitability.